1903, the pharmaceutical factory was built in New Jersey.

1933, the research branch was established and became the predecessor of the famous Merck Institute.

1953, merged with Dongsha Company and formally established Merck Company.

1992, Merck China Company was established.

1993, acquired Medco Company and entered the field of health care.

1998, Merck established a business ethics office to ensure that the lofty ethics and values of the company will continue to be observed.

From 1998 to 2000, Merck acquired a series of innovative biotechnology companies, such as Biogen, Synaptic, Vical and Sibia Neurosciences, which further strengthened its scientific research strength.

In March 2009, Merck announced that it had reached a cooperation agreement with Schering-Plough, and Merck acquired Schering-Plough in the form of $46,543.8 billion in cash and stock. At present, the merger of the two companies still needs the approval of European and American regulatory authorities.

On June 3, 2009, 165438+ Merck announced the completion of the merger procedure with Schering-Plough, and the shares of the two companies merged into one.

On June 4, 2009, Merck announced that the new company after the merger of the two companies officially began to operate.